Camomy Trial: A Prospective Randomized Clinical Trial To Compare Six-Months Sputum Conversion Rate With A Clarithromycin Or Moxifloxacin Containing Regimen In Patients With AM. Xenopi Pulmonary Infection: intermediate Analysis - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue American Journal of Respiratory and Critical Care Medicine Année : 2016

Camomy Trial: A Prospective Randomized Clinical Trial To Compare Six-Months Sputum Conversion Rate With A Clarithromycin Or Moxifloxacin Containing Regimen In Patients With AM. Xenopi Pulmonary Infection: intermediate Analysis

(1, 2) , (3) , , (4) , (5) , , , , (6, 7) , , , (8, 9) , , , (10) , , (11, 12) , (1, 2)
1
2
3
4
5
6
7
8
9
10
11
12
Fichier non déposé

Dates et versions

hal-03591343 , version 1 (28-02-2022)

Identifiants

  • HAL Id : hal-03591343 , version 1

Citer

Claire Andrejak, N. Veziris, F. -X. Lescure, H. Mal, D. Bouvry, et al.. Camomy Trial: A Prospective Randomized Clinical Trial To Compare Six-Months Sputum Conversion Rate With A Clarithromycin Or Moxifloxacin Containing Regimen In Patients With AM. Xenopi Pulmonary Infection: intermediate Analysis. American Journal of Respiratory and Critical Care Medicine, 2016, 193. ⟨hal-03591343⟩
21 Consultations
0 Téléchargements

Partager

Gmail Facebook Twitter LinkedIn More